The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 1.56 — grey zone — between safe and distressedWatch
- Earnings-manipulation signal · Beneish M -2.17 — no flag raisedOK
- Earnings quality 94/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as Jin Medical International Ltd. reports it. History and quarterly detail are in the app.
- Wheelchair$16.2M
- Other Products$2.6M
- Wheelchair Components$1.9M
Latest filings
- 6-K · Company announcement (foreign filer)2026-08-04
- 6-K · Company announcement (foreign filer)2026-07-20
- 6-K · Company announcement (foreign filer)2026-07-15
- 6-K · Company announcement (foreign filer)2026-06-29
- 6-K · Company announcement (foreign filer)2026-06-04
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Jin Medical International Ltd., every answer cited to the official filings🔒
- The Intelligence Brief — added when Jin Medical International Ltd.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.